{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T08:07:02Z","timestamp":1759133222897},"reference-count":64,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1016\/j.radonc.2005.07.001","type":"journal-article","created":{"date-parts":[[2005,9,14]],"date-time":"2005-09-14T22:49:52Z","timestamp":1126738192000},"page":"241-250","source":"Crossref","is-referenced-by-count":40,"title":["The multidisciplinary rectal cancer treatment: Main convergences, controversial aspects and investigational areas which support the need for an European Consensus"],"prefix":"10.1016","volume":"76","author":[{"given":"Vincenzo","family":"Valentini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bengt","family":"Glimelius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce D.","family":"Minsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Van Cutsem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanry","family":"Bartelink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Regina G.H.","family":"Beets-Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Pierre","family":"Gerard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paris","family":"Kosmidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Pahlman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aurelio","family":"Picciocchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phil","family":"Quirke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel","family":"Tepper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Tonato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelius J.","family":"Van de Velde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Numa","family":"Cellini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Latini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.radonc.2005.07.001_bib1","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1001\/jama.1990.03450110090034","article-title":"Adjuvant therapy for patients with colon and rectal cancer","volume":"264","year":"1990","journal-title":"JAMA"},{"key":"10.1016\/j.radonc.2005.07.001_bib2","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S0360-3016(98)00470-2","article-title":"The accuracy of transrectal ultrasound in predicting the pathological stage of low-lying rectal cancer after preoperative chemoradiation therapy","volume":"43","author":"Barbaro","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2005.07.001_bib3","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/BF02236553","article-title":"Usefulness of endorectal ultrasound after preoperative radiotherapy in rectal cancer","volume":"43","author":"Gavioli","year":"2000","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.radonc.2005.07.001_bib4","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00384-003-0480-5","article-title":"Rectal cancer: how accurate can imaging predict the T stage and the circumferential resection margin?","volume":"18","author":"Beets-Tan","year":"2003","journal-title":"Int J Colorec Dis"},{"key":"10.1016\/j.radonc.2005.07.001_bib5","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(00)04040-X","article-title":"Accuracy of magnetic resonance imaging in prediction of tumor-free resection margin in rectal cancer surgery","volume":"357","author":"Beets-Tan","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2005.07.001_bib6","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1148\/radiol.2272011747","article-title":"Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histopathologic comparison","volume":"227","author":"Brown","year":"2003","journal-title":"Radiology"},{"key":"10.1016\/j.radonc.2005.07.001_bib7","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0140-6736(02)09520-X","article-title":"Diffusion MRI for prediction of response of rectal cancer to chemoradiation","volume":"360","author":"Dzik-Jurask","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2005.07.001_bib8","first-page":"145a","article-title":"Prospective evaluation of the prognostic significance of FDG-PET assessment of rectal cancer response to preoperative chemoradiation","volume":"21","author":"Guillem","year":"2002","journal-title":"Proc ASCO"},{"key":"10.1016\/j.radonc.2005.07.001_bib9","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1200\/JCO.1992.10.8.1218","article-title":"Combined modality therapy of rectal cancer: Decreased acute toxicity with the pre-operative approach","volume":"10","author":"Minsky","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2005.07.001_bib10","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1001\/jama.284.8.1008","article-title":"Preoperative radiotherapy for resectable rectal cancer: A meta-analysis","volume":"284","author":"Camma","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.radonc.2005.07.001_bib11","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/S0140-6736(01)06409-1","article-title":"Adjuvant therapy for rectal cancer: a systematic overview of 8507 patients from 22 randomised trials","volume":"358","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2005.07.001_bib12","series-title":"Adjuvant radiotherapy in operable rectal cancer: a systematic review","author":"Munro","year":"2002"},{"key":"10.1016\/j.radonc.2005.07.001_bib13","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1080\/02841860310012301","article-title":"Cavallin-st\u00e5hl E A systematic overview of radiation therapy effects in rectal cancer","volume":"42","author":"Glimelius","year":"2003","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2005.07.001_bib14","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1056\/NEJM199704033361402","article-title":"Improved survival with preoperative radiotherapy in resectable rectal cancer","volume":"336","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2005.07.001_bib15","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1056\/NEJMoa010580","article-title":"Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer","volume":"345","author":"Kapiteijn","year":"2001","journal-title":"New Engl J Med"},{"key":"10.1016\/j.radonc.2005.07.001_bib16","first-page":"127a","article-title":"Preoperative radiotherapy and TME-surgery for rectal cancer: detailed analysis in relation to quality control in a randomized trial","volume":"21","author":"van de Velde","year":"2002","journal-title":"Proc ASCO"},{"key":"10.1016\/j.radonc.2005.07.001_bib17","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1200\/JCO.20.3.817","article-title":"Acute side effects and complications after short-term preoperative radiotherapy combined with total mesorectal excision in primary rectal cancer: Report of a multicenter randomized trial","volume":"20","author":"Marijnen","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2005.07.001_bib18","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00384-003-0520-1","article-title":"Neoadjuvant radiation and chemotherapy in rectal cancer does not increase postoperative complications","volume":"18","author":"Valero","year":"2003","journal-title":"Int J Colorec Dis"},{"key":"10.1016\/j.radonc.2005.07.001_bib19","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s10434-001-0801-2","article-title":"Complete response to neoadjuvant chemoradiation for rectal cancer does not influence survival","volume":"8","author":"Onaitis","year":"2001","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.radonc.2005.07.001_bib20","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/00000421-200104000-00001","article-title":"Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancer","volume":"24","author":"Janjan","year":"2001","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.radonc.2005.07.001_bib21","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S1072-7515(01)01159-0","article-title":"Assessing the predictive value of clinical complete response to neoadjuvant therapy for rectal cancer: an analysis of 488 patients","volume":"194","author":"Hiotis","year":"2002","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.radonc.2005.07.001_bib22","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00000658-200207000-00012","article-title":"Long-term prognostic significance of extent of rectal cancer response to preoperative radiation and chemotherapy","volume":"236","author":"Ruo","year":"2002","journal-title":"Ann Surg"},{"key":"10.1016\/j.radonc.2005.07.001_bib23","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S0360-3016(02)02764-5","article-title":"Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long term analysis of 165 patients","volume":"53","author":"Valentini","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2005.07.001_bib24","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s10350-004-6545-x","article-title":"A pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treated by mesorectal excision","volume":"46","author":"Garcia-Aguilar","year":"2003","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.radonc.2005.07.001_bib25","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0360-3016(00)00732-X","article-title":"Prognostic significance of postchemoradiation stage following preoperative chemotherapy and radiation for advanced\/recurrent rectal cancers","volume":"48","author":"Mohiuddin","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2005.07.001_bib26","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1002\/1097-0142(19950501)75:9<2269::AID-CNCR2820750913>3.0.CO;2-I","article-title":"The Stockholm I trial of preoperative short term radiotherapy in operable rectal carcinoma","volume":"75","author":"Cedermark","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2005.07.001_bib27","first-page":"3505","article-title":"Preoperative radiotherapy (Preop RT) in rectal canacer: effect and timing of additional chemotherapy (CT) 5 year results of the EORTC 22921 trial","author":"Bosset","year":"2005","journal-title":"Proc ASCO"},{"key":"10.1016\/j.radonc.2005.07.001_bib28","first-page":"3504","article-title":"Preoperative (preop) radiotherapy (RT) +5FU\/folinic acid (FA) in T3-4 rectal cancers: results of the FFCD 9203 randomized trial","author":"Gerard","year":"2005","journal-title":"Proc. ASCO"},{"key":"10.1016\/j.radonc.2005.07.001_bib29","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.radonc.2003.12.006","article-title":"Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy","volume":"72","author":"Bujko","year":"2004","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2005.07.001_bib30","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1056\/NEJMoa040694","article-title":"Preoperative versus postoperative chemoradiotherapy for rectal cancer","volume":"351","author":"Sauer","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2005.07.001_bib31","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0167-8140(96)01867-1","article-title":"Short-term preoperative radiotherapy results in down-staging of rectal cancer: a study of 1316 patients","volume":"43","author":"Graf","year":"1997","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2005.07.001_bib32","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1200\/JCO.2001.19.7.1976","article-title":"No downstaging after short-term preoperative radiotherapy in rectal cancer patients","volume":"19","author":"Marijnen","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2005.07.001_bib33","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s10350-004-6172-6","article-title":"Restorative and nonrestorative surgery for low rectal cancer after high dose radiation. Long term oncologic and functional results","volume":"45","author":"Rouanet","year":"2002","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.radonc.2005.07.001_bib34","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0360-3016(98)00180-1","article-title":"Sphincter preservation with preoperative radiation therapy and coloanal anastomosis: long term follow-up","volume":"42","author":"Wagman","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2005.07.001_bib35","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0360-3016(01)01618-2","article-title":"Ten years of preoperative chemoradiation for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, and sphincter preservation in three consecutive studies","volume":"51","author":"Valentini","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"10.1016\/j.radonc.2005.07.001_bib36","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1200\/JCO.2003.02.505","article-title":"Phase I\/II trial of capecitibine, oxaliplatin, and radiation for rectal cancer","volume":"21","author":"Rodel","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2005.07.001_bib37","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1200\/JCO.2003.10.045","article-title":"Preoperative concurrent chemoradiotherapy in locally advanced rectal cancer with high-dose radiation and oxaliplatin-containing regimen: the Lyon R0-04 phase II trial","volume":"21","author":"Gerard","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2005.07.001_bib38","first-page":"132a","article-title":"A phase I\u2013II study of weekly oxaliplatin (OXA) 5-fluorouracil (FU) continuous infusion (CI) and preoperative radiotherapy (RT) in locally advanced rectal cancer (LARC)","volume":"21","author":"Aschele","year":"2002","journal-title":"Proc ASCO"},{"key":"10.1016\/j.radonc.2005.07.001_bib39","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/S0360-3016(03)00326-2","article-title":"Preoperative hyperfractionated accelerated radiotherapy (HART) and concomitant CPT-11 in locally advanced rectal carcinoma: a phase I study","volume":"56","author":"Voelter","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2005.07.001_bib40","first-page":"345","article-title":"Phase I\/II study of irinotecan (CPT-11), 5-fluorouracil and concurrent radiotherapy for the treatment of T3\u2013T4 locally advanced inoperable rectal cancer","volume":"22","author":"Levine","year":"2003","journal-title":"Proc ASCO"},{"key":"10.1016\/j.radonc.2005.07.001_bib41","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/S0360-3016(03)00275-X","article-title":"Multicenter dose-finding study of concurrent capecitabine and radiotherapy as adjuvant treatment for operable rectal cancer","volume":"56","author":"Souglakos","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2005.07.001_bib42","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1200\/JCO.2002.02.049","article-title":"Phase I trial evaluating the concurrent combination of radiotherapy and capecitabine in rectal cancer","volume":"20","author":"Dunst","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2005.07.001_bib43","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1200\/JCO.1999.17.8.2396","article-title":"Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: The Lyon R90-01 randomized trial","volume":"17","author":"Francois","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2005.07.001_bib44","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1200\/JCO.2004.08.170","article-title":"Improved sphincter preservation in low rectal cancer with high-dose preoperative radiotherapy: the lyon r96-02 randomized trial","volume":"22","author":"Gerard","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2005.07.001_bib45","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199103143241101","article-title":"Effective surgical adjuvant therapy for high-risk rectal carcinoma","volume":"324","author":"Krook","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2005.07.001_bib46","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1056\/NEJM199408253310803","article-title":"Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery","volume":"331","author":"O'Connell","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2005.07.001_bib47","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1200\/JCO.2002.07.132","article-title":"Adjuvant therapy in rectal cancer: analysis of stage, sex, and local control\u2014final report of Intergroup 0114","volume":"20","author":"Tepper","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2005.07.001_bib48","first-page":"251","volume":"22","author":"Smalley","year":"2003","journal-title":"Proc ASCO"},{"key":"10.1016\/j.radonc.2005.07.001_bib49","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1200\/JCO.2002.07.037","article-title":"Randomized trial of postoperative adjuvant therapy in stage II and III rectal cancer to define the optimal sequence of chemotherapy and radiotherapy: A preliminary report","volume":"20","author":"Lee","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2005.07.001_bib50","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/BF02237122","article-title":"Prognostic factors in stage T3N0 rectal cancer. Do all patients require post-operative pelvic irradiation and chemotherapy?","volume":"42","author":"Willett","year":"1999","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.radonc.2005.07.001_bib51","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S1091-255X(99)80087-0","article-title":"T3N0 rectal cancer: results following sharp mesorectal excision and no adjuvant therapy","volume":"3","author":"Merchant","year":"1999","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.radonc.2005.07.001_bib52","first-page":"251","article-title":"A new TNM staging strategy for node-positive (stage III) rectal cancer: an analysis of 5998 patients","volume":"22","author":"Green","year":"2003","journal-title":"Proc ASCO"},{"key":"10.1016\/j.radonc.2005.07.001_bib53","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/00000658-199411000-00012","article-title":"The long term effect of adjuvant postoperative chemoradiotherapy for rectal cancer on bowel function","volume":"220","author":"Kollmorgen","year":"1994","journal-title":"Ann Surg"},{"key":"10.1016\/j.radonc.2005.07.001_bib54","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1200\/JCO.2004.08.173","article-title":"Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis","volume":"22","author":"Gunderson","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2005.07.001_bib55","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1200\/JCO.2003.11.126","article-title":"Superiority of oxaliplatin and fluorouracil-leucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil-leucovorin: interim results of a phase III trial","volume":"21","author":"Rothenberg","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2005.07.001_bib56","first-page":"252","article-title":"N9741: oxaliplatin (Oxal) or CPT-11+5-fluorouracil (5-FU)\/Leucovorin (LV) or oxal + CPT-11 in advanced colorectal cancer (CRC). Updated efficacy and quality of life","volume":"22","author":"Goldberg","year":"2003","journal-title":"Proc ASCO"},{"key":"10.1016\/j.radonc.2005.07.001_bib57","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJM200009283431302","article-title":"Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer","volume":"343","author":"Saltz","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2005.07.001_bib58","first-page":"252","article-title":"Cetuximab (C225) alone or in combination with irinotecan (CPT-11) in patients with epidermal growth factor receptor (EGFR)-positive, irinotecan-refractory metastatic colorectal cancer (MCRC)","volume":"22","author":"Cunningham","year":"2003","journal-title":"Proc ASCO"},{"key":"10.1016\/j.radonc.2005.07.001_bib59","first-page":"687","article-title":"Oxaliplatin plus raltitrexed in the treatment of patients with advanced colorectal cancer: a phase II study","volume":"23","author":"Martoni","year":"2003","journal-title":"Anticancer Res"},{"key":"10.1016\/j.radonc.2005.07.001_bib60","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/00001813-200208000-00006","article-title":"Raltitrexed plus oxaliplatin as a first-line chemotherapy in metastatic colorectal carcinoma: a multicentric phase II trial","volume":"13","author":"Neri","year":"2002","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.radonc.2005.07.001_bib61","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/annonc\/mdf183","article-title":"Multicenter non-randomized phase II study of raltitrexed (Tomudex) and oxaliplatin in non-pretreated metastatic colorectal cancer patients","volume":"13","author":"Seitz","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1016\/j.radonc.2005.07.001_bib62","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1038\/sj.bjc.6601676","article-title":"Oral capecitabine vs intravenous 5-fluorouracil and leucovorin: integrated efficacy data and novel analyses from two large, randomized, phase III trials","volume":"90","author":"Van Cutsem","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.radonc.2005.07.001_bib63","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/annonc\/mdf091","article-title":"Raltitrexed plus oxaliplatin (TOMOX) as first-line chemotherapy for metastatic colorectal cancer. A phase II study of the Italian Group for the Study of Gastrointestinal Tract Carcinomas (GISCAD)","volume":"13","author":"Cascinu","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1016\/j.radonc.2005.07.001_bib64","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/02841860510029798","article-title":"Targeted drugs in metastatic colorectal cancer with special emphasis on guidelines for the use of bevacizumab and cetuximab: An Acta Oncologica expert report","volume":"44","author":"Nygren","year":"2005","journal-title":"Acta Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814005003324?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814005003324?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T04:26:12Z","timestamp":1548131172000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814005003324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":64,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["S0167814005003324"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2005.07.001","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2005,9]]}}}